The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frey, B. M.
Right arrow Articles by Moore, M. A.S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frey, B. M.
Right arrow Articles by Moore, M. A.S.
The Journal of Immunology, 1998, 160: 691-699.
Copyright © 1998 by The American Association of Immunologists

Adenovector-Mediated Expression of Human Thrombopoietin cDNA in Immune-Compromised Mice: Insights into the Pathophysiology of Osteomyelofibrosis1

Beat M. Frey2,*, Shahin Rafii{dagger}, Michael Teterson§, Dan Eaton§, Ronald G. Crystal{ddagger} and Malcolm A.S. Moore*

* James Ewing Laboratory of Developmental Hematopoiesis, Sloan-Kettering Institute for Cancer Research, Divisions of {dagger} Hematology/Oncology and {ddagger} Pulmonary and Critical Care Medicine, The New York Hospital-Cornell Medical Center, New York, NY 10021; and § Cardiovascular Research Department, Genentech, Inc., South San Francisco, CA 94080

Thrombopoietin (TPO) cDNA can be effectively delivered in vivo by adenovectors. Immune normal mice (BALB/c) and syngeneic mice with variable degrees of immune dysfunction nu, SCID, and NOD-SCID) were treated with an adenovirus vector expressing the human TPO cDNA (AdTPO). Platelet peaks were significantly higher in SCID and NOD-SCID mice compared with BALB/c and nu mice. Human plasma TPO concentration correlated with the platelet counts. SCID and NOD-SCID mice exhibited also granulocytosis and increased numbers of hemopoietic progenitors in bone marrow. Following platelet peak, BALB/c mice developed autoantibodies against murine TPO leading to thrombocytopenia and depletion of megakaryocytes and hemopoietic progenitors in bone marrow. AdTPO-treated SCID mice developed osteomyelofibrosis and extramedullary/extrasplenal hemopoiesis. In contrast, NOD-SCID mice with a similar magnitude of TPO overexpression did not show fibrotic changes in bone marrow. We conclude, first, that a chronic high level of TPO overexpression stimulates megakaryocytopoiesis and myelopoiesis leading to thrombocytosis and granulocytosis. Second, increased megakaryocytopoiesis is not sufficient for development of secondary osteomyelofibrosis. The functionally deficient monocytes and macrophages of NOD-SCID mice probably prevented fibrotic marrow changes. Third, immune deficiency enhances expression of adenovirally mediated transgenes, and fourth, xenogeneic transgene delivered by adenovector to a host with normal immune functions may induce loss of immune tolerance and autoimmune phenomenon.




This article has been cited by other articles:


Home page
 BloodHome page
D. J. Kuter, G. J. Mufti, B. J. Bain, R. P. Hasserjian, W. Davis, and M. Rutstein
Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim
Blood, October 29, 2009; 114(18): 3748 - 3756.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. J. Kuter
New thrombopoietic growth factors
Blood, June 1, 2007; 109(11): 4607 - 4616.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
O. Wagner-Ballon, H. Chagraoui, E. Prina, M. Tulliez, G. Milon, H. Raslova, J.-L. Villeval, W. Vainchenker, and S. Giraudier
Monocyte/Macrophage Dysfunctions Do Not Impair the Promotion of Myelofibrosis by High Levels of Thrombopoietin.
J. Immunol., June 1, 2006; 176(11): 6425 - 6433.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Tefferi
Pathogenesis of Myelofibrosis With Myeloid Metaplasia
J. Clin. Oncol., November 20, 2005; 23(33): 8520 - 8530.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H. Chagraoui, M. Tulliez, T. Smayra, E. Komura, S. Giraudier, T. Yun, N. Lassau, W. Vainchenker, and F. Wendling
Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO
Blood, April 15, 2003; 101(8): 2983 - 2989.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
J. L. Spivak, G. Barosi, G. Tognoni, T. Barbui, G. Finazzi, R. Marchioli, and M. Marchetti
Chronic Myeloproliferative Disorders
Hematology, January 1, 2003; 2003(1): 200 - 224.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. L. Spivak
Polycythemia vera: myths, mechanisms, and management
Blood, December 15, 2002; 100(13): 4272 - 4290.
[Full Text] [PDF]

Home page
 BloodHome page
H. Chagraoui, E. Komura, M. Tulliez, S. Giraudier, W. Vainchenker, and F. Wendling
Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice
Blood, November 15, 2002; 100(10): 3495 - 3503.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
S. Giraudier, H. Chagraoui, E. Komura, S. Barnache, B. Blanchet, J. P. LeCouedic, D. F. Smith, F. Larbret, A.-L. Taksin, F. Moreau-Gachelin, et al.
Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors
Blood, September 26, 2002; 100(8): 2932 - 2940.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. M. Vannucchi, L. Bianchi, C. Cellai, F. Paoletti, R. A. Rana, R. Lorenzini, G. Migliaccio, and A. R. Migliaccio
Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1low mice)
Blood, July 30, 2002; 100(4): 1123 - 1132.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Hattori, B. Heissig, K. Tashiro, T. Honjo, M. Tateno, J.-H. Shieh, N. R. Hackett, M. S. Quitoriano, R. G. Crystal, S. Rafii, et al.
Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells
Blood, June 1, 2001; 97(11): 3354 - 3360.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
K. Hattori, S. Dias, B. Heissig, N. R. Hackett, D. Lyden, M. Tateno, D. J. Hicklin, Z. Zhu, L. Witte, R. G. Crystal, et al.
Vascular Endothelial Growth Factor and Angiopoietin-1 Stimulate Postnatal Hematopoiesis by Recruitment of Vasculogenic and Hematopoietic Stem Cells
J. Exp. Med., May 7, 2001; 193(9): 1005 - 1014.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. Ramalingam, S. Rafii, S. Worgall, N. R. Hackett, and R. G. Crystal
Induction of Endogenous Genes following Infection of Human Endothelial Cells with an E1- E4+ Adenovirus Gene Transfer Vector
J. Virol., December 1, 1999; 73(12): 10183 - 10190.
[Abstract] [Full Text]

Home page
 JCOHome page
G. Barosi
Myelofibrosis With Myeloid Metaplasia: Diagnostic Definition and Prognostic Classification for Clinical Studies and Treatment Guidelines
J. Clin. Oncol., September 1, 1999; 17(9): 2954 - 2954.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Ramalingam, S. Rafii, S. Worgall, D. E. Brough, and R. G. Crystal
E1-E4+ Adenoviral Gene Transfer Vectors Function as a "Pro-Life" Signal to Promote Survival of Primary Human Endothelial Cells
Blood, May 1, 1999; 93(9): 2936 - 2944.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. L. Taksin, J.-P. L. Couedic, I. Dusanter-Fourt, A. Masse, S. Giraudier, A. Katz, F. Wendling, W. Vainchenker, N. Casadevall, and N. Debili
Autonomous Megakaryocyte Growth in Essential Thrombocythemia and Idiopathic Myelofibrosis Is Not Related to a c-mpl Mutation or to an Autocrine Stimulation by Mpl-L
Blood, January 1, 1999; 93(1): 125 - 139.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1998 by The American Association of Immunologists, Inc. All rights reserved.